Viewing Study NCT05286320


Ignite Creation Date: 2025-12-25 @ 4:11 AM
Ignite Modification Date: 2025-12-25 @ 4:11 AM
Study NCT ID: NCT05286320
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-03-02
First Post: 2022-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
Sponsor: National Taiwan University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module